Lymphocyte	NN	B-NP	B-protein	Other	###	1	Lymphocyte	Lymphocyte	NN	NN	_	3	compound	_	_
glucocorticoid	NN	I-NP	I-protein	B-Protein	###	2	glucocorticoid	glucocorticoid	NN	NN	_	3	compound	_	_
receptor	NN	I-NP	I-protein	I-Protein	###	3	receptor	receptor	NN	NN	_	0	root	_	_
:	:	O	O	Other	###	4	:	:	:	:	_	3	punct	_	_
predictor	NN	B-NP	O	Other	###	5	predictor	predictor	NN	NN	_	3	dep	_	_
of	IN	B-PP	O	Other	###	6	of	of	IN	IN	_	8	case	_	_
sertraline	NN	B-NP	O	Other	###	7	sertraline	sertraline	NN	NN	_	8	compound	_	_
response	NN	I-NP	O	Other	###	8	response	response	NN	NN	_	5	nmod	_	_
in	IN	B-PP	O	Other	###	9	in	in	IN	IN	_	13	case	_	_
adolescent	JJ	B-NP	O	Other	###	10	adolescent	adolescent	JJ	JJ	_	13	amod	_	_
major	JJ	I-NP	O	Other	###	11	major	major	JJ	JJ	_	13	amod	_	_
depressive	JJ	I-NP	O	Other	###	12	depressive	depressive	JJ	JJ	_	13	amod	_	_
disorder	NN	I-NP	O	Other	###	13	disorder	disorder	NN	NN	_	8	nmod	_	_
(	(	O	O	Other	###	14	(	(	(	(	_	15	punct	_	_
MDD	NN	B-NP	O	Other	###	15	MDD	MDD	NN	NN	_	13	appos	_	_
)	)	O	O	Other	###	16	)	)	)	)	_	15	punct	_	_
.	.	O	O	Other	###	17	.	.	.	.	_	3	punct	_	_

Major	JJ	B-NP	O	Other	###	1	Major	Major	JJ	JJ	_	3	amod	_	_
depressive	JJ	I-NP	O	Other	###	2	depressive	depressive	JJ	JJ	_	3	amod	_	_
disorder	NN	I-NP	O	Other	###	3	disorder	disorder	NN	NN	_	9	nsubj	_	_
(	(	O	O	Other	###	4	(	(	(	(	_	5	punct	_	_
MDD	NN	B-NP	O	Other	###	5	MDD	MDD	NN	NN	_	3	appos	_	_
)	)	O	O	Other	###	6	)	)	)	)	_	5	punct	_	_
in	IN	B-PP	O	Other	###	7	in	in	IN	IN	_	8	case	_	_
adolescents	NNS	B-NP	O	Other	###	8	adolescents	adolescents	NNS	NNS	_	3	nmod	_	_
demonstrates	VBZ	B-VP	O	Other	###	9	demonstrates	demonstrates	VBZ	VBZ	_	0	root	_	_
resistance	NN	B-NP	O	Other	###	10	resistance	resistance	NN	NN	_	9	dobj	_	_
to	TO	B-PP	O	Other	###	11	to	to	TO	TO	_	13	case	_	_
tricyclic	JJ	B-NP	O	Other	###	12	tricyclic	tricyclic	JJ	JJ	_	13	amod	_	_
antidepressants	NNS	I-NP	O	Other	###	13	antidepressants	antidepressants	NNS	NNS	_	10	nmod	_	_
and	CC	O	O	Other	###	14	and	and	CC	CC	_	10	cc	_	_
absence	NN	B-NP	O	Other	###	15	absence	absence	NN	NN	_	10	conj	_	_
of	IN	B-PP	O	Other	###	16	of	of	IN	IN	_	17	case	_	_
hypercortisolemia	NN	B-NP	O	Other	###	17	hypercortisolemia	hypercortisolemia	NN	NN	_	15	nmod	_	_
.	.	O	O	Other	###	18	.	.	.	.	_	9	punct	_	_

The	DT	B-NP	O	Other	###	1	The	The	DT	DT	_	2	det	_	_
efficacy	NN	I-NP	O	Other	###	2	efficacy	efficacy	NN	NN	_	11	nsubj	_	_
of	IN	B-PP	O	Other	###	3	of	of	IN	IN	_	6	case	_	_
serotonin	NN	B-NP	O	Other	###	4	serotonin	serotonin	NN	NN	_	6	compound	_	_
reuptake	NN	I-NP	O	Other	###	5	reuptake	reuptake	NN	NN	_	6	compound	_	_
inhibitors	NNS	I-NP	O	Other	###	6	inhibitors	inhibitors	NNS	NNS	_	2	nmod	_	_
(	(	O	O	Other	###	7	(	(	(	(	_	8	punct	_	_
SRIs	NNS	B-NP	O	Other	###	8	SRIs	SRIs	NNS	NNS	_	6	appos	_	_
)	)	O	O	Other	###	9	)	)	)	)	_	8	punct	_	_
is	VBZ	B-VP	O	Other	###	10	is	is	VBZ	VBZ	_	11	cop	_	_
uncertain	JJ	B-ADJP	O	Other	###	11	uncertain	uncertain	JJ	JJ	_	0	root	_	_
,	,	O	O	Other	###	12	,	,	,	,	_	11	punct	_	_
and	CC	O	O	Other	###	13	and	and	CC	CC	_	11	cc	_	_
response	NN	B-NP	O	Other	###	14	response	response	NN	NN	_	15	compound	_	_
predictors	NNS	I-NP	O	Other	###	15	predictors	predictors	NNS	NNS	_	17	nsubj	_	_
are	VBP	B-VP	O	Other	###	16	are	are	VBP	VBP	_	17	cop	_	_
unavailable	JJ	B-ADJP	O	Other	###	17	unavailable	unavailable	JJ	JJ	_	11	conj	_	_
.	.	O	O	Other	###	18	.	.	.	.	_	11	punct	_	_

Abnormal	JJ	B-NP	O	Other	###	1	Abnormal	Abnormal	JJ	JJ	_	3	amod	_	_
fast	JJ	I-NP	O	Other	###	2	fast	fast	JJ	JJ	_	3	amod	_	_
feedback	NN	I-NP	O	Other	###	3	feedback	feedback	NN	NN	_	11	nsubj	_	_
and	CC	O	O	Other	###	4	and	and	CC	CC	_	3	cc	_	_
negative	JJ	B-NP	O	Other	###	5	negative	negative	JJ	JJ	_	6	amod	_	_
feedback	NN	I-NP	O	Other	###	6	feedback	feedback	NN	NN	_	3	conj	_	_
of	IN	B-PP	O	Other	###	7	of	of	IN	IN	_	10	case	_	_
the	DT	B-NP	O	Other	###	8	the	the	DT	DT	_	10	det	_	_
hypothalamic-pituitary-adrenal	JJ	I-NP	O	Other	###	9	hypothalamic-pituitary-adrenal	hypothalamic-pituitary-adrenal	JJ	JJ	_	10	amod	_	_
axis	NN	I-NP	O	Other	###	10	axis	axis	NN	NN	_	3	nmod	_	_
implicates	VBZ	B-VP	O	Other	###	11	implicates	implicates	VBZ	VBZ	_	0	root	_	_
a	DT	B-NP	O	Other	###	12	a	a	DT	DT	_	18	det	_	_
dampened	JJ	I-NP	O	Other	###	13	dampened	dampened	JJ	JJ	_	18	amod	_	_
limbic-hippocampal	JJ	I-NP	B-protein	Other	###	14	limbic-hippocampal	limbic-hippocampal	JJ	JJ	_	18	amod	_	_
glucocorticoid	NN	I-NP	I-protein	B-Protein	###	15	glucocorticoid	glucocorticoid	NN	NN	_	18	compound	_	_
type	NN	I-NP	I-protein	I-Protein	###	16	type	type	NN	NN	_	18	compound	_	_
II	CD	I-NP	I-protein	I-Protein	###	17	II	II	CD	CD	_	18	nummod	_	_
receptor	NN	I-NP	I-protein	I-Protein	###	18	receptor	receptor	NN	NN	_	11	dobj	_	_
(	(	O	O	Other	###	19	(	(	(	(	_	20	punct	_	_
GCII	NN	B-NP	B-protein	B-Protein	###	20	GCII	GCII	NN	NN	_	18	appos	_	_
)	)	O	O	Other	###	21	)	)	)	)	_	20	punct	_	_
.	.	O	O	Other	###	22	.	.	.	.	_	11	punct	_	_

We	PRP	B-NP	O	Other	###	1	We	We	PRP	PRP	_	2	nsubj	_	_
hypothesized	VBD	B-VP	O	Other	###	2	hypothesized	hypothesized	VBD	VBD	_	0	root	_	_
that	IN	B-SBAR	O	Other	###	3	that	that	IN	IN	_	7	mark	_	_
lymphocyte	NN	B-NP	B-protein	Other	###	4	lymphocyte	lymphocyte	NN	NN	_	5	compound	_	_
GCII	NN	I-NP	I-protein	B-Protein	###	5	GCII	GCII	NN	NN	_	7	nsubjpass	_	_
is	VBZ	B-VP	O	Other	###	6	is	is	VBZ	VBZ	_	7	auxpass	_	_
altered	VBN	I-VP	O	Other	###	7	altered	altered	VBN	VBN	_	2	ccomp	_	_
in	IN	B-PP	O	Other	###	8	in	in	IN	IN	_	10	case	_	_
adolescent	JJ	B-NP	O	Other	###	9	adolescent	adolescent	JJ	JJ	_	10	amod	_	_
MDD	NN	I-NP	O	Other	###	10	MDD	MDD	NN	NN	_	7	nmod	_	_
and	CC	O	O	Other	###	11	and	and	CC	CC	_	7	cc	_	_
could	MD	B-VP	O	Other	###	12	could	could	MD	MD	_	13	aux	_	_
serve	VB	I-VP	O	Other	###	13	serve	serve	VB	VB	_	7	conj	_	_
as	IN	B-PP	O	Other	###	14	as	as	IN	IN	_	16	case	_	_
a	DT	B-NP	O	Other	###	15	a	a	DT	DT	_	16	det	_	_
marker	NN	I-NP	O	Other	###	16	marker	marker	NN	NN	_	13	nmod	_	_
for	IN	B-PP	O	Other	###	17	for	for	IN	IN	_	18	case	_	_
response	NN	B-NP	O	Other	###	18	response	response	NN	NN	_	16	nmod	_	_
to	TO	B-PP	O	Other	###	19	to	to	TO	TO	_	20	case	_	_
SRIs	NNS	B-NP	B-protein	Other	###	20	SRIs	SRIs	NNS	NNS	_	18	nmod	_	_
.	.	O	O	Other	###	21	.	.	.	.	_	2	punct	_	_

In	IN	B-PP	O	Other	###	1	In	In	IN	IN	_	4	case	_	_
an	DT	B-NP	O	Other	###	2	an	an	DT	DT	_	4	det	_	_
open-label	JJ	I-NP	O	Other	###	3	open-label	open-label	JJ	JJ	_	4	amod	_	_
study	NN	I-NP	O	Other	###	4	study	study	NN	NN	_	17	nmod	_	_
,	,	O	O	Other	###	5	,	,	,	,	_	17	punct	_	_
adolescents	NNS	B-NP	O	Other	###	6	adolescents	adolescents	NNS	NNS	_	17	nsubj	_	_
(	(	O	O	Other	###	7	(	(	(	(	_	8	punct	_	_
n	NN	B-NP	O	Other	###	8	n	n	NN	NN	_	6	dep	_	_
=	SYM	B-VP	O	Other	###	9	=	=	SYM	SYM	_	8	amod	_	_
20	CD	B-NP	O	Other	###	10	20	20	CD	CD	_	9	dep	_	_
)	)	O	O	Other	###	11	)	)	)	)	_	8	punct	_	_
meeting	VBG	B-VP	O	Other	###	12	meeting	meeting	VBG	VBG	_	6	acl	_	_
DSM-III-R	NN	B-NP	O	Other	###	13	DSM-III-R	DSM-III-R	NN	NN	_	14	compound	_	_
criteria	NNS	I-NP	O	Other	###	14	criteria	criteria	NNS	NNS	_	12	dobj	_	_
for	IN	B-PP	O	Other	###	15	for	for	IN	IN	_	16	case	_	_
MDD	NN	B-NP	O	Other	###	16	MDD	MDD	NN	NN	_	14	nmod	_	_
showed	VBD	B-VP	O	Other	###	17	showed	showed	VBD	VBD	_	0	root	_	_
baseline	NN	B-NP	O	Other	###	18	baseline	baseline	NN	NN	_	21	compound	_	_
lymphocyte	NN	I-NP	O	Other	###	19	lymphocyte	lymphocyte	NN	NN	_	21	compound	_	_
GCII	NN	I-NP	O	B-Protein	###	20	GCII	GCII	NN	NN	_	21	compound	_	_
sites	NNS	I-NP	O	Other	###	21	sites	sites	NNS	NNS	_	17	dobj	_	_
per	IN	B-PP	O	Other	###	22	per	per	IN	IN	_	23	case	_	_
cell	NN	B-NP	O	Other	###	23	cell	cell	NN	NN	_	29	nmod	_	_
(	(	O	O	Other	###	24	(	(	(	(	_	25	punct	_	_
sites	NN	B-NP	O	Other	###	25	sites	sites	NN	NN	_	29	compound	_	_
/	/	O	O	Other	###	26	/	/	/	/	_	27	punct	_	_
cell	NN	B-NP	O	Other	###	27	cell	cell	NN	NN	_	25	appos	_	_
)	)	O	O	Other	###	28	)	)	)	)	_	27	punct	_	_
values	NNS	B-NP	O	Other	###	29	values	values	NNS	NNS	_	18	dep	_	_
of	IN	B-PP	O	Other	###	30	of	of	IN	IN	_	31	case	_	_
793	CD	B-NP	O	Other	###	31	793	793	CD	CD	_	29	nmod	_	_
+/-	SYM	I-NP	O	Other	###	32	+/-	+/-	SYM	SYM	_	31	cc	_	_
106	CD	I-NP	O	Other	###	33	106	106	CD	CD	_	31	conj	_	_
versus	IN	I-NP	O	Other	###	34	versus	versus	IN	IN	_	31	cc	_	_
2	CD	I-NP	O	Other	###	35	2	2	CD	CD	_	31	conj	_	_
,	,	I-NP	O	Other	###	36	,	,	,	,	_	35	punct	_	_
563	CD	I-NP	O	Other	###	37	563	563	CD	CD	_	35	nummod	_	_
+/-	CC	I-NP	O	Other	###	38	+/-	+/-	CC	CC	_	35	cc	_	_
499	CD	I-NP	O	Other	###	39	499	499	CD	CD	_	35	conj	_	_
(	(	O	O	Other	###	40	(	(	(	(	_	42	punct	_	_
+/-	SYM	O	O	Other	###	41	+/-	+/-	SYM	SYM	_	42	cc	_	_
SEM	NN	O	O	Other	###	42	SEM	SEM	NN	NN	_	35	appos	_	_
)	)	O	O	Other	###	43	)	)	)	)	_	42	punct	_	_
for	IN	B-PP	O	Other	###	44	for	for	IN	IN	_	46	case	_	_
matched	VBN	B-NP	O	Other	###	45	matched	matched	VBN	VBN	_	46	amod	_	_
controls	NNS	I-NP	O	Other	###	46	controls	controls	NNS	NNS	_	35	nmod	_	_
(	(	O	O	Other	###	47	(	(	(	(	_	48	punct	_	_
n	NN	B-NP	O	Other	###	48	n	n	NN	NN	_	46	dep	_	_
=	SYM	B-VP	O	Other	###	49	=	=	SYM	SYM	_	48	amod	_	_
18	CD	B-NP	O	Other	###	50	18	18	CD	CD	_	49	dep	_	_
)	)	O	O	Other	###	51	)	)	)	)	_	48	punct	_	_
(	(	O	O	Other	###	52	(	(	(	(	_	53	punct	_	_
t	NN	B-NP	O	Other	###	53	t	t	NN	NN	_	46	dep	_	_
=	JJ	B-VP	O	Other	###	54	=	=	JJ	JJ	_	53	amod	_	_
3.5	CD	B-NP	O	Other	###	55	3.5	3.5	CD	CD	_	54	dep	_	_
;	:	O	O	Other	###	56	;	;	:	:	_	53	punct	_	_
df	NN	B-NP	O	Other	###	57	df	df	NN	NN	_	53	dep	_	_
=	JJ	B-VP	O	Other	###	58	=	=	JJ	JJ	_	57	amod	_	_
36	CD	B-NP	O	Other	###	59	36	36	CD	CD	_	58	dep	_	_
;	:	O	O	Other	###	60	;	;	:	:	_	53	punct	_	_
p	NN	B-NP	O	Other	###	61	p	p	NN	NN	_	53	dep	_	_
<	JJR	B-NP	O	Other	###	62	<	<	JJR	JJR	_	61	amod	_	_
.001	CD	I-NP	O	Other	###	63	.001	.001	CD	CD	_	62	dep	_	_
)	)	O	O	Other	###	64	)	)	)	)	_	53	punct	_	_
.	.	O	O	Other	###	65	.	.	.	.	_	17	punct	_	_

GCII	NN	B-NP	B-protein	B-Protein	###	1	GCII	GCII	NN	NN	_	4	nsubjpass	_	_
was	VBD	B-VP	O	Other	###	2	was	was	VBD	VBD	_	4	auxpass	_	_
bimodally	RB	I-VP	O	Other	###	3	bimodally	bimodally	RB	RB	_	4	advmod	_	_
distributed	VBN	I-VP	O	Other	###	4	distributed	distributed	VBN	VBN	_	0	root	_	_
,	,	O	O	Other	###	5	,	,	,	,	_	4	punct	_	_
with	IN	B-PP	O	Other	###	6	with	with	IN	IN	_	9	mark	_	_
SRI	NN	B-NP	O	Other	###	7	SRI	SRI	NN	NN	_	8	compound	_	_
responders	NNS	I-NP	O	Other	###	8	responders	responders	NNS	NNS	_	9	nsubj	_	_
differing	VBG	B-VP	O	Other	###	9	differing	differing	VBG	VBG	_	4	advcl	_	_
from	IN	B-PP	O	Other	###	10	from	from	IN	IN	_	11	case	_	_
nonresponders	NNS	B-NP	O	Other	###	11	nonresponders	nonresponders	NNS	NNS	_	9	nmod	_	_
(	(	O	O	Other	###	12	(	(	(	(	_	13	punct	_	_
t	NN	B-NP	O	Other	###	13	t	t	NN	NN	_	11	dep	_	_
=	JJ	B-VP	O	Other	###	14	=	=	JJ	JJ	_	13	amod	_	_
3.9	CD	B-NP	O	Other	###	15	3.9	3.9	CD	CD	_	14	dep	_	_
;	:	O	O	Other	###	16	;	;	:	:	_	13	punct	_	_
df	NN	B-NP	O	Other	###	17	df	df	NN	NN	_	13	dep	_	_
=	JJ	B-VP	O	Other	###	18	=	=	JJ	JJ	_	17	amod	_	_
14	CD	B-NP	O	Other	###	19	14	14	CD	CD	_	18	dep	_	_
;	:	O	O	Other	###	20	;	;	:	:	_	13	punct	_	_
p	NN	B-NP	O	Other	###	21	p	p	NN	NN	_	13	dep	_	_
<	JJR	B-NP	O	Other	###	22	<	<	JJR	JJR	_	21	amod	_	_
.001	CD	I-NP	O	Other	###	23	.001	.001	CD	CD	_	22	dep	_	_
)	)	O	O	Other	###	24	)	)	)	)	_	13	punct	_	_
.	.	O	O	Other	###	25	.	.	.	.	_	4	punct	_	_

GCII	NN	B-NP	B-protein	B-Protein	###	1	GCII	GCII	NN	NN	_	3	nsubj	_	_
accurately	RB	B-ADVP	O	Other	###	2	accurately	accurately	RB	RB	_	3	advmod	_	_
classified	VBD	B-VP	O	Other	###	3	classified	classified	VBD	VBD	_	0	root	_	_
90	CD	B-NP	O	Other	###	4	90	90	CD	CD	_	5	nummod	_	_
percent	NN	I-NP	O	Other	###	5	percent	percent	NN	NN	_	3	dobj	_	_
of	IN	B-PP	O	Other	###	6	of	of	IN	IN	_	8	case	_	_
sertraline	NN	B-NP	O	Other	###	7	sertraline	sertraline	NN	NN	_	8	compound	_	_
responders	NNS	I-NP	O	Other	###	8	responders	responders	NNS	NNS	_	5	nmod	_	_
and	CC	O	O	Other	###	9	and	and	CC	CC	_	5	cc	_	_
80	CD	B-NP	O	Other	###	10	80	80	CD	CD	_	11	nummod	_	_
percent	NN	I-NP	O	Other	###	11	percent	percent	NN	NN	_	5	conj	_	_
of	IN	B-PP	O	Other	###	12	of	of	IN	IN	_	13	case	_	_
nonresponders	NNS	B-NP	O	Other	###	13	nonresponders	nonresponders	NNS	NNS	_	11	nmod	_	_
.	.	O	O	Other	###	14	.	.	.	.	_	3	punct	_	_

Only	RB	B-NP	O	Other	###	1	Only	Only	RB	RB	_	3	advmod	_	_
SRI	NN	I-NP	O	Other	###	2	SRI	SRI	NN	NN	_	3	compound	_	_
responders	NNS	I-NP	O	Other	###	3	responders	responders	NNS	NNS	_	4	nsubj	_	_
showed	VBD	B-VP	O	Other	###	4	showed	showed	VBD	VBD	_	0	root	_	_
GCII	NN	B-NP	B-protein	B-Protein	###	5	GCII	GCII	NN	NN	_	6	compound	_	_
sites	NNS	I-NP	O	Other	###	6	sites	sites	NNS	NNS	_	4	dobj	_	_
/	/	O	O	Other	###	7	/	/	/	/	_	6	punct	_	_
cell	NNS	I-NP	O	Other	###	8	cell	cell	NNS	NNS	_	6	dep	_	_
upregulated	VBN	B-VP	O	Other	###	9	upregulated	upregulated	VBN	VBN	_	6	acl	_	_
after	IN	B-PP	O	Other	###	10	after	after	IN	IN	_	12	case	_	_
6	CD	B-NP	O	Other	###	11	6	6	CD	CD	_	12	nummod	_	_
weeks	NNS	I-NP	O	Other	###	12	weeks	weeks	NNS	NNS	_	9	nmod	_	_
of	IN	B-PP	O	Other	###	13	of	of	IN	IN	_	14	case	_	_
treatment	NN	B-NP	O	Other	###	14	treatment	treatment	NN	NN	_	12	nmod	_	_
(	(	O	O	Other	###	15	(	(	(	(	_	16	punct	_	_
t	NN	B-NP	O	Other	###	16	t	t	NN	NN	_	6	dep	_	_
=	JJ	B-VP	O	Other	###	17	=	=	JJ	JJ	_	16	amod	_	_
2.1	CD	B-NP	O	Other	###	18	2.1	2.1	CD	CD	_	17	dep	_	_
,	,	O	O	Other	###	19	,	,	,	,	_	16	punct	_	_
df	NN	B-NP	O	Other	###	20	df	df	NN	NN	_	16	appos	_	_
=	JJ	B-VP	O	Other	###	21	=	=	JJ	JJ	_	20	amod	_	_
10	CD	B-NP	O	Other	###	22	10	10	CD	CD	_	21	dep	_	_
;	:	O	O	Other	###	23	;	;	:	:	_	16	punct	_	_
p	NN	B-NP	O	Other	###	24	p	p	NN	NN	_	16	dep	_	_
<	JJR	B-NP	O	Other	###	25	<	<	JJR	JJR	_	24	amod	_	_
.05	CD	I-NP	O	Other	###	26	.05	.05	CD	CD	_	25	dep	_	_
)	)	O	O	Other	###	27	)	)	)	)	_	16	punct	_	_
.	.	O	O	Other	###	28	.	.	.	.	_	4	punct	_	_

